STRIATAL D2 ACETYLCHOLINE INTERACTIONS - PET STUDIES OF THE VESAMICOL RECEPTOR

被引:36
作者
INGVAR, M
STONEELANDER, S
ROGERS, GA
JOHANSSON, B
ERIKSSON, L
PARSONS, SM
WIDEN, L
机构
[1] KAROLINSKA PHARM,S-10401 STOCKHOLM,SWEDEN
[2] UNIV CALIF SANTA BARBARA,SANTA BARBARA,CA 93106
[3] KAROLINSKA INST,S-10401 STOCKHOLM 60,SWEDEN
关键词
ACETYLCHOLINE; DOPAMINE; VESAMICOL RECEPTOR; AMINOBENZOVESAMICOL; HALOPERIDOL; F-18; POSITRON EMISSION TOMOGRAPHY;
D O I
10.1097/00001756-199309150-00006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
THE regional cerebral distribution of [F-18]NEFA, an aminobenzovesamicol (ABV), was studied in primates with PET. The binding was stereoselective and could be blocked but not displaced with vesamicol. The regional distribution pattern at late times, striatum > cortex > cerebellum, was corroborated by in vitro autoradiography using [H-3]ABV and is consistent with known patterns of cholinergic innervation. Pretreatment with sigma1 or D1 antagonists did not affect the striatal uptake, whereas D2 antagonists markedly augmented the uptake. This is consistent with the known induction of acetylcholine turnover in the striatum in response to D2-receptor blockade and demonstrates that the amount of [F-18]-(-)-NEFA incorporated was influenced by the cholinergic activity in the target neurones.
引用
收藏
页码:1311 / 1314
页数:4
相关论文
共 22 条
[1]   A KINETIC AND ALLOSTERIC MODEL FOR THE ACETYLCHOLINE TRANSPORTER-VESAMICOL RECEPTOR IN SYNAPTIC VESICLES [J].
BAHR, BA ;
CLARKSON, ED ;
ROGERS, GA ;
NOREMBERG, K ;
PARSONS, SM .
BIOCHEMISTRY, 1992, 31 (25) :5752-5762
[2]   CHOLINERGIC BLOCKADE AS A MODEL OF THE COGNITIVE DEFICITS IN ALZHEIMERS-DISEASE [J].
CHRISTENSEN, H ;
MALTBY, N ;
JORM, AF ;
CREASEY, H ;
BROE, GA .
BRAIN, 1992, 115 :1681-1699
[3]  
Cummings J L, 1987, Alzheimer Dis Assoc Disord, V1, P128, DOI 10.1097/00002093-198701030-00003
[4]  
DEWEY SL, 1990, SYNAPSE, V6, P321
[5]  
Efange S. M. N., 1993, Journal of Labelled Compounds and Radiopharmaceuticals, V32, P311
[6]   OPPOSING EFFECTS OF D-1 AND D-2 RECEPTOR ANTAGONISTS ON ACETYLCHOLINE LEVELS IN THE RAT STRIATUM [J].
FAGE, D ;
SCATTON, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) :359-362
[7]  
GREENAMYRE JT, 1993, CEREBROVAS BRAIN MET, V5, P61
[8]   EFFECTS OF DOPAMINERGIC RECEPTOR AGONISTS AND ANTAGONISTS ON ACTIVITY OF NEO-STRIATAL CHOLINERGIC SYSTEM [J].
GUYENET, PG ;
AGID, Y ;
JAVOY, F ;
BEAUJOUAN, JC ;
ROSSIER, J ;
GLOWINSKI, J .
BRAIN RESEARCH, 1975, 84 (02) :227-244
[9]   HIGH-AFFINITY CHOLINE TRANSPORT REGULATION BY DRUG ADMINISTRATION DURING POSTNATAL-DEVELOPMENT [J].
HAPPE, HK ;
MURRIN, LC .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (06) :2053-2059
[10]   MOUSE-BRAIN DISTRIBUTION OF A C-11 LABELED VESAMICOL DERIVATIVE - PRESYNAPTIC MARKER OF CHOLINERGIC NEURONS [J].
KILBOURN, MR ;
JUNG, YW ;
HAKA, MS ;
GILDERSLEEVE, DL ;
KUHL, DE ;
WIELAND, DM .
LIFE SCIENCES, 1990, 47 (21) :1955-1963